Premier Path Wealth Partners, LLC
- SEC CIK
- 0001999925
- Latest filing
- Jul 21, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Premier Path Wealth Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,265
- Value
- $328.0K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,265 | $328.0K | <0.1% | −2,000−9.9% | Reduced | Holders |
| Q1 2026 | 20,265 | $281.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 20,265 | $244.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 20,265 | $275.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 20,265 | $129.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 20,265 | $71.7K | <0.1% | +20,265 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −20,265−100.0% | Sold out | Holders |
| Q3 2024 | 20,265 | $65.7K | <0.1% | +20,265 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −20,265−100.0% | Sold out | Holders |
| Q1 2024 | 20,265 | $57.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 20,265 | $298.3K | 0.1% | – | No prior filing | Holders |